The Cancer Letter

Inside information on cancer research and drug development

In Brief

James B. Yu named associate chief medical officer for radiation oncology at Smilow

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

James B. Yu, was named associate chief medical officer for radiation oncology for Smilow Cancer Hospital and Smilow Cancer Hospital Network.

A professor of therapeutic radiology at Yale School of Medicine and Smilow Cancer Hospital, Yu specializes in treating genitourinary cancers, including kidney, bladder, prostate, and central nervous system cancers and cases requiring Gamma Knife stereotactic radiosurgery.

Yu is a member of the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale. Through his work in COPPER, Yu’s research centers on the comparative effectiveness of new radiation technologies and how these new technologies are adopted nationally.

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more
By Kimlin Tam Ashing, Nadine J. Barrett, Kim F. Rhoads, Folakemi T. Odedina, Hayley S. Thompson and Camille C. R. Ragin
Table of Contents

Login

Looking for IP Login?